Uriyel / 02

Clinical Research

A mobile-first operational layer for research teams that need approved study information, controlled content and workflow actions available without relying on paper circulation and disconnected messages.

EnvironmentClinical research operations
FunctionStudy information and workflow support
StatusProduct development / controlled pilot use
BoundaryNot a clinical decision or treatment system
Operating problem

Research teams move. Paper does not move well with them.

Study information and operational changes need to be accessible, current and controlled. Uriyel Clinical Research structures approved content around the research workflow so teams can find the right information and see what requires action.

01

Select

Move from condition or research area to the relevant approved study.

02

Read

Present approved study information in a mobile-first format.

03

Act

Make operational actions and responsibilities visible to authorised users.

04

Update

Allow controlled content changes through an authorised administration path.

05

Trace

Maintain clear provenance around what changed and who approved the update.

06

Govern

Keep deployment boundaries, user roles and information handling explicit.

Interface demonstration

Fast access to controlled study information.

The sample below is a fictional interface demonstration. It does not contain patient information and does not imply approval, endorsement or deployment by any healthcare organisation.

Clinical Research / Study workspaceDemonstration data
Research area / Demonstration

Approved study information

04Active demo studies
02Content updates
01Action requiring review
ST-014Eligibility and visit referenceApproved
UP-022Study contact information revisedPublished
AC-006Review operational note before next visitReview
AD-003Pending controlled-content updateAdmin

Fictional demonstration data. No patient data, live study data or healthcare-organisation endorsement is represented.

Clinical boundary

Operational workflow, not clinical authority.

The public product position remains deliberately narrow until the relevant governance, information-security and deployment requirements are defined for each environment.

Supports

Approved study information, workflow navigation, authorised content updates, action visibility and provenance.

Does not provide

Diagnosis, treatment recommendations, clinical judgement, protocol interpretation beyond approved content, or autonomous clinical decisions.

Deployment

Any live use should be governed by the relevant organisation’s technical, information-governance, security and research requirements.

Product development

Clinical Research stays deliberately bounded.

View shared architecture